Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
Clinical trial NCT00281008 · COMPLETED
Trial details
- NCT number
- NCT00281008
- Sponsor
- Kastle Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-07-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.